1,068
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis

, , , , , , , , , , , & , PhD show all
Pages 653-663 | Received 21 Mar 2016, Accepted 19 Jun 2016, Published online: 17 Aug 2016

References

  • Van Dijk BA, Gatta G, Capocaccia R, Pierannunzio D, Strojan P, Licitra L, Group RW. Rare cancers of the head and neck area in Europe. Eur J Cancer 2012; 48:783-96; PMID:22051735; http://dx.doi.org/10.1016/j.ejca.2011.08.021
  • Gourin CG, Conger BT, Porubsky ES, Sheils WC, Bilodeau PA, Coleman TA. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma. Laryngoscope 2008; 118:1191-4; PMID:18391764; http://dx.doi.org/10.1097/MLG.0b013e31816e2eb7
  • Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005; 115:629-39; PMID:15805872; http://dx.doi.org/10.1097/01.mlg.0000161338.54515.b1
  • Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ CK. SEER Cancer Statistics Review (CSR), 1975-2012 [Internet]. 2015; Available from: http://seer.cancer.gov/archive/csr/1975_2012/
  • Baatenburg de Jong RJ, Rongen RJ, Laméris JS, Harthoorn M, Verwoerd CD, Knegt P. Metastatic neck disease. Palpation vs ultrasound examination. Arch Otolaryngol Head Neck Surg 1989; 115:689-90; PMID:2655666; http://dx.doi.org/10.1001/archotol.1989.01860300043013
  • Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, Yeung HWD, Huvos AG, Shah JP, Larson SM, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 2006; 47:755-62; PMID:16644744.
  • Liao LJ, Lo WC, Hsu WL, Wang CT, Lai MS. Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities. BMC Cancer 2012; 12:236; PMID:22691269; http://dx.doi.org/10.1186/1471-2407-12-236
  • Chu HR, Kim JH, Yoon DY, Hwang HS, Rho Y-S. Additional diagnostic value of (18)F-FDG PET-CT in detecting retropharyngeal nodal metastases. Otolaryngol Head Neck Surg 2009; 141:633-8; PMID:19861203; http://dx.doi.org/10.1016/j.otohns.2009.08.008
  • Melchers LJ, Schuuring E, van Dijk BAC, de Bock GH, Witjes MJH, van der Laan BFAM, van der Wal JE, Roodenburg JLN. Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol 2012; 48:337-42; PMID:22130455; http://dx.doi.org/10.1016/j.oraloncology.2011.11.007
  • Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev 2011; 11:726-34; PMID:21941284; http://dx.doi.org/10.1038/nrc3130.
  • Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev 2012; 13:679-92; PMID:22945394; http://dx.doi.org/10.1038/nrg3270
  • Roossink F, de Jong S, Wisman GB, van der Zee AG, Schuuring E. DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art. Cell Oncol (Dordr) 2012; 35:231-41; PMID:22836879; http://dx.doi.org/10.1007/s13402-012-0091-7
  • Kwon MJ, Kwon JH, Nam ES, Shin HS, Lee DJ, Kim JH, Rho YS, Sung CO, Lee WJ, Cho SJ. TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma. Hum Pathol 2013; 44:1722-9; PMID:23664538; http://dx.doi.org/10.1016/j.humpath.2013.03.004
  • Zhang P, Wang J, Gao W, Yuan BZ, Rogers J, Reed E. CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer. Mol Cancer 2004; 3:14; PMID:15125777; http://dx.doi.org/10.1186/1476-4598-3-14
  • Gao T, He B, Pan Y, Gu L, Chen L, Nie Z, Xu Y, Li R, Wang S. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway. Clin Transl Oncol 2013; 16:410-7; PMID:23943562; http://dx.doi.org/10.1007/s12094-013-1098-x
  • Pierini S, Jordanov SH, Mitkova AV, Chalakov IJ, Melnicharov MB, Kunev KV, Mitev VI, Kaneva RP, Goranova TE. Promoter hypermethylation of CDKN2A, MGMT, MLH1 and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients. Head Neck 2013; 36:1103-8; PMID:23804521; http://dx.doi.org/10.1002/hed.23413
  • Melchers LJ, Clausen MJAM, Mastik MF, Slagter-Menkema L, van der Wal JE, Wisman GBA, Roodenburg JLN, Schuuring E. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma. Epigenetics 2015; 10:850-60; PMID:26213212; http://dx.doi.org/10.1080/15592294.2015.1075689
  • Clausen MJAM, Melchers LJ, Mastik MF, Slagter-Menkema L, Groen HJM, van der Laan BFAM, van Criekinge W, de Meyer T, Denil S, Wisman GBA, et al. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma. Gene Chromosomes Canc er 2016; 55:45-59; PMID:26391330; http://dx.doi.org/10.1002/gcc.22310
  • Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006; 5:37-50; PMID:16485345; http://dx.doi.org/10.1038/nrd1930
  • Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, Tilanus MG, Koole R, Hordijk GJ, van der Vliet PC, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005; 37:182-6; PMID:15640797; http://dx.doi.org/10.1038/ng1502
  • Roepman P, Kemmeren P, Wessels LF, Slootweg PJ, Holstege FC. Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res 2006; 66:2361-6; PMID:16489042; http://dx.doi.org/10.1158/0008-5472.CAN-05-3960
  • van Hooff SR, Leusink FK, Roepman P, Baatenburg de Jong RJ, Speel EJ, van den Brekel MW, van Velthuysen ML, van Diest PJ, van Es RJ, Merkx MA, et al. Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. J Clin Oncol 2012; 30:4104-10; PMID:23045589; http://dx.doi.org/10.1200/JCO.2011.40.4509
  • Melchers LJ, Bruine de Bruin L, Schnell U, Slagter-Menkema L, Mastik MF, de Bock GH, van Dijk BA, Giepmans BN, van der Laan BF, van der Wal JE, et al. Lack of claudin-7 is a strong predictor of regional recurrence in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2013; 49:998-1005; PMID:23953778; http://dx.doi.org/10.1016/j.oraloncology.2013.07.008
  • Melchers LJ, Mastik MF, Samaniego Cameron B, van Dijk BA, de Bock GH, van der Laan BF, van der Vegt B, Speel EJ, Roodenburg JL, Witjes MJ, et al. Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye. Br J Cancer 2015; 112:1349-57; PMID:25867270; http://dx.doi.org/10.1038/bjc.2015.99
  • Yang N, Eijsink JJ, Lendvai A, Volders HH, Klip H, Buikema HJ, van Hemel BM, Schuuring E, van der Zee AG, Wisman GB. Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers Prev 2009; 18:3000-7; PMID:19843677; http://dx.doi.org/10.1158/1055-9965.EPI-09-0405
  • Eijsink JJ, Lendvai A, Deregowski V, Klip HG, Verpooten G, Dehaspe L, de Bock GH, Hollema H, van Criekinge W, Schuuring E, et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J cancerJournal Int du cancer 2012; 130:1861-9; PMID:21796628; http://dx.doi.org/10.1002/ijc.26326
  • van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17:2257-317; PMID:14671650; http://dx.doi.org/10.1038/sj.leu.2403202
  • Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10:R25; PMID:19261174; http://dx.doi.org/ 10.1186/gb-2009-10-3-r25
  • Hardcastle TJ, Kelly KA. baySeq: empirical Bayesian methods for identifying differential expression in sequence count data. BMC Bioinformatics 2010; 11:422-35; PMID:20698981; http://dx.doi.org/10.1186/1471-2105-11-422
  • Uniport Consortium. Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res 2014; 42:D191-8; PMID:24253303; http://dx.doi.org/10.1093/nar/gkt1140
  • Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24:1547-8; PMID:18467348; http://dx.doi.org/10.1093/bioinformatics/btn224
  • Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43(7):e47; PMID:25605792; http://dx.doi.org/10.1093/nar/gkv007
  • Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2:401-4; PMID:22588877; http://dx.doi.org/10.1158/2159-8290.CD-12-0095
  • Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6:pl1; PMID:23550210; http://dx.doi.org/10.1126/scisignal.2004088
  • R Development Core Team. R: A Language and Environment for Statistical Computing [Internet]. 2015; Available from: http://www.R-project.org/
  • Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res 2015; 43:D146-52; PMID:25378301; http://dx.doi.org/10.1093/nar/gku1104
  • Cheng JM, Ding M, Aribi A, Shah P, Rao K. Loss of RAB25 expression in breast cancer. Int J cancer 2006; 118:2957-64; PMID:16395697; http://dx.doi.org/10.1002/ijc.21739
  • Tong M, Chan KW, Bao JY, Wong KY, Chen JN, Kwan PS, Tang KH, Fu L, Qin YR, Lok S, et al. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Cancer Res 2012; 72:6024-35; PMID:22991305; http://dx.doi.org/10.1158/0008-5472.CAN-12-1269
  • Tellez-Gabriel M, Arroyo-Solera I, Leon X, Gallardo A, Lopez M, Cespedes MV, Casanova I, Lopez-Pousa A, Quer M, Mangues MA, et al. High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma. Cancer Med 2013; 2:950-63; PMID:24403269; http://dx.doi.org/10.1002/cam4.153
  • Chua CE, Tang BL. The role of the small GTPase Rab31 in cancer. J Cell Mol Med 2015; 19:1-10; PMID:25472813; http://dx.doi.org/10.1111/jcmm.12403
  • Mitra S, Cheng KW, Mills GB. Rab25 in cancer: a brief update. Biochem Soc Trans 2012; 40:1404-8; PMID:23176489; http://dx.doi.org/10.1042/BST20120249
  • Cheng KW, Lahad JP, Gray JW, Mills GB. Emerging role of RAB GTPases in cancer and human disease. Cancer Res 2005; 65:2516-9; PMID:15805241; http://dx.doi.org/10.1158/0008-5472.CAN-05-0573
  • Recchi C, Seabra MC. Novel functions for Rab GTPases in multiple aspects of tumour progression. Biochem Soc Trans 2012; 40:1398-403; PMID:23176488; http://dx.doi.org/10.1042/BST20120199
  • Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N, Liu J, Smith-McCune K, Lu KH, Fishman D, et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004; 10:1251-6; PMID:15502842; http://dx.doi.org/10.1038/nm1125
  • Zhang J, Wei J, Lu J, Tong Z, Liao B, Yu B, Zheng F, Huang X, Chen Z, Fang Y, et al. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3beta/Snail signaling. Carcinogenesis 2013; 34:2401-8; PMID:23722651; http://dx.doi.org/10.1093/carcin/bgt187
  • Cao C, Lu C, Xu J, Zhang J, Zhang J, Li M. Expression of Rab25 correlates with the invasion and metastasis of gastric cancer. Chin J Cancer Res 2013; 25:192-9; PMID:23592900; http://dx.doi.org/10.3978/j.issn.1000-9604.2013.03.01
  • Yin YX, Shen F, Pei H, Ding Y, Zhao H, Zhao M, Chen Q. Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis. Tumour Biol 2012; 33:1581-7; PMID:22644676; http://dx.doi.org/10.1007/s13277-012-0412-5
  • Amornphimoltham P, Rechache K, Thompson J, Masedunskas A, Leelahavanichkul K, Patel V, Molinolo A, Gutkind JS, Weigert R. Rab25 regulates invasion and metastasis in head and neck cancer. Clin Cancer Res 2013; 19(6):1375-88; PMID:23340300; http://dx.doi.org/10.1158/1078-0432.CCR-12-2858
  • Cheng JM, Volk L, Janaki DK, Vyakaranam S, Ran S, Rao KA. Tumor suppressor function of Rab25 in triple-negative breast cancer. Int J Cancer 2010; 126(12):2799-81; PMID:19795443; http://dx.doi.org/10.1002/ijc.24900
  • Wrzeszczynski KO, Varadan V, Byrnes J, Lum E, Kamalakaran S, Levine DA, Dimitrova N, Zhang MQ, Lucito R. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. PLoS One 2011; 6:e28503; PMID:22174824; http://dx.doi.org/10.1371/journal.pone.0028503
  • Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358:1148-59; PMID:18337604; http://dx.doi.org/10.1056/NEJMra072067
  • Azad N, Zahnow CA, Rudin CM, Baylin SB. The future of epigenetic therapy in solid tumours-lessons from the past. Nat Rev Oncol 2013; 10:256-66; PMID:23546521; http://dx.doi.org/10.1038/nrclinonc.2013.42
  • Arantes LM, de Carvalho AC, Melendez ME, Carvalho AL, Goloni-Bertollo EM. Methylation as a biomarker for head and neck cancer. Oral Oncol 2014; 50:587-92; PMID:24656975; http://dx.doi.org/10.1016/j.oraloncology.2014.02.015
  • Wu CY, Tseng RC, Hsu HS, Wang YC, Hsu MT. Frequent down-regulation of hRAB37 in metastatic tumor by genetic and epigenetic mechanisms in lung cancer. Lung Cancer 2009; 63:360-7; PMID:18687502; http://dx.doi.org/10.1016/j.lungcan.2008.06.014
  • Tanaka T, Arai M, Wu S, Kanda T, Miyauchi H, Imazeki F, Matsubara H, Yokosuka O. Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer. Oncol Rep 2011; 26:1329-35; PMID:21785829; http://dx.doi.org/10.3892/or.2011.1401
  • Price ME, Cotton AM, Lam LL, Farre P, Emberly E, Brown CJ, Robinson WP, Kobor MS. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin 2013; 6:4; PMID:23452981; http://dx.doi.org/10.1186/1756-8935-6-4